The estimated Net Worth of Martin J Duvall is at least $950 mil dollars as of 28 May 2019. Martin Duvall owns over 5,000 units of Tocagen stock worth over $949,629 and over the last 7 years Martin sold TOCA stock worth over $0.
Martin has made over 1 trades of the Tocagen stock since 2019, according to the Form 4 filled with the SEC. Most recently Martin bought 5,000 units of TOCA stock worth $21,700 on 28 May 2019.
The largest trade Martin's ever made was buying 5,000 units of Tocagen stock on 28 May 2019 worth over $21,700. On average, Martin trades about 625 units every 0 days since 2017. As of 28 May 2019 Martin still owns at least 13,605 units of Tocagen stock.
You can see the complete history of Martin Duvall stock trades at the bottom of the page.
Martin's mailing address filed with the SEC is 3030 Bunker Hill St #230, San Diego, CA 92109, USA.
Over the last 7 years, insiders at Tocagen have traded over $0 worth of Tocagen stock and bought 339,950 units worth $1,867,749 . The most active insiders traders include Faheem Hasnain, Steven Michael Oliveira y Franklin M Berger. On average, Tocagen executives and independent directors trade stock every 99 days with the average trade being worth of $2,157,169. The most recent stock trade was executed by Steven Michael Oliveira on 14 April 2020, trading 74,301 units of TOCA stock currently worth $88,418.
Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.
Tocagen executives and other stock owners filed with the SEC include: